Posts by: Kara Elam

Kara Elam

Kara Elam is currently working on her Doctorate in Health Policy. She holds Master Degrees in both epidemiology and microbiology. Her research interests include emerging viral diseases, the intersection of human rights and intellectual property rights, and ending violence against women.

November 11, 2015November 11, 2015

Positive Value of Immunosequencing for Diagnosis of Cutaneous T-Cell Lymphoma

News

Adaptive Biotechnologies has published a study demonstrating that their revolutionary immunosequencing platform, which utilizes next-generation sequencing and advanced bioinformatics to sensitively profile all T cells in a biological sample, provides a more ... Read more

October 16, 2015October 16, 2015

Organ Transplant Drug May Increase Risk of Rare Form of Lymphoma

News

Recently, a group of clinical researchers from Johns Hopkins Hospital (JHH) released study results revealing that the immunosuppressive drug mycophenolate mofetil (MMF) may be linked to an increased risk of central ... Read more

October 5, 2015October 5, 2015

Specific Biomarkers Can Predict How Certain Lymphoma Patients Respond to Treatment

News

University of Queensland researchers have recently discovered an immunological biomarker in patients with a specific type of non-Hodgkin’s lymphoma that can be used for early assessment of a patient’s response ... Read more

September 4, 2015September 9, 2015

Combined Lenalidomide/Rituximab Treatment Demonstrated Improved Clinical Response In Patients With Recurrent Follicular Lymphoma

News

A collaborative team of interdisciplinary researchers have released results from a clinical trial showing that rituximab in combination with the drug lenalidomide leads to better outcomes for patients with follicular ... Read more

September 1, 2015September 1, 2015

Phase II Study of Investigational Medicine Venetoclax Meets Primary Endpoint With Positive Results

News

Genentech in partnership with AbbVie Pharmaceuticals and the Leukemia & Lymphoma Society (LLS), recently announced positive results from a Phase 1 clinical trial for venetoclax, an investigational therapy to treat patients with ... Read more

July 22, 2015September 4, 2015

Study Findings Show PET Adapted Treatment Beneficial For Stages I/II Hodgkin Lymphoma

News

This week the European Organization for Research and Treatment of Cancer (EORTC) whose mission it is to develop, conduct, coordinate, and stimulate translational and clinical research in Europe to improve ... Read more

June 26, 2015August 23, 2016

Rituximab and Thiotepa Improves Outcomes in Primary CNS Lymphoma Patients

News

During the recent International Conference on Malignant Lymphoma in Lugano, Switzerland, researchers from the International Extra-nodal Lymphoma Study Group (IELSG) led by Andrés Ferreri, MD, Ospedale San Raffaele, Milano, Italy, presented ... Read more

June 25, 2015June 25, 2015

Researchers Discover Epigenetic Fingerprint May Improve Individual Patient Treatment

News

A collaborative team of international researchers led by Dr. Thai H. Ho, MD., PhD, associate professor of medicine and nutrition at the Mayo Clinic has made an important discovery that ... Read more

June 19, 2015August 23, 2016

Donors With High T Cell Counts A Better Match For Stem-Cell Transplant Patients

News

Researchers from the University of Pennsylvania’s Abramson Cancer Center (ACC) have recently released study findings suggesting that screening for donor T cell characteristics will improve donor selection and lead to ... Read more